ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Letter In Response To Hadley; RFA Available

July 7, 1995

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

12 Minority CCOPs Awardees Names, San Antonio Gets 2

September 21, 1990

ASCO Proposes Two IOM Workshops On Changing Clinical Trials Group System

September 17, 2010

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

Communication Is Key To Clinical Trial Enrollment

June 30, 2006